E-LIB Suche - Ergebnisse für: Strickland, Stephen

1

POSTER: AML-475 Activity, Tolerability, and Resistance Prof..:

Erba, Harry ; Wang, Eunice ; Issa, Ghayas...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S168 , 2023

2

POSTER: CML-590 ASC4START: A Phase 3b, Open-Label, Randomiz..:

Strickland, Stephen ; Andorsky, David ; Brümmendorf, Tim...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S178 , 2023

Link: https://doi.org/10.1016/..

3

AML-475 Activity, Tolerability, and Resistance Profile of t..:

Erba, Harry ; Wang, Eunice ; Issa, Ghayas...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S304-S305 , 2023

Link: https://doi.org/10.1016/..

4

CML-590 ASC4START: A Phase 3b, Open-Label, Randomized Study..:

Strickland, Stephen ; Andorsky, David ; Brümmendorf, Tim...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S349-S350 , 2023

Link: https://doi.org/10.1016/..

5

TP53 Mutations Are Associated with Increased Infections and..:

Marvin-Peek, Jennifer ; Mason, Emily F. ; Kishtagari, Ashwin...
Transplantation and Cellular Therapy. 29 (2023) 6 - p. 390.e1-390.e10 , 2023

Link: https://doi.org/10.1016/..

6

Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory..:

Perl, Alexander E. ; Larson, Richard A. ; Podoltsev, Nikolai A....
Transplantation and Cellular Therapy. 29 (2023) 4 - p. 265.e1-265.e10 , 2023

Link: https://doi.org/10.1016/..

7

Follow-up of patients with R/R FLT3-mutation–positive AML t..:

Perl, Alexander E. ; Larson, Richard A. ; Podoltsev, Nikolai A....
Blood. 139 (2022) 23 - p. 3366-3375 , 2022

Link: https://doi.org/10.1182/..

8

59. Constellation of rare genetic abnormalities associated ..:

Yenamandra, Ashwini ; Guess, Tiffany ; Gardner, Amibeth...
Cancer Genetics. 260-261 (2022) - p. 20 , 2022

Link: https://doi.org/10.1016/..

9

Diagnosis and treatment of therapy-related acute myeloid le..:

Strickland, Stephen A. ; Vey, Norbert
Critical Reviews in Oncology/Hematology. 171 (2022) - p. 103607 , 2022

Link: https://doi.org/10.1016/..

10

Factors Affecting Low Hematopoietic Cell Transplantation Ra..:

Marvin-Peek, Jennifer ; Mason, Emily ; Jayani, Reena V...
Transplantation and Cellular Therapy. 28 (2022) 3 - p. S128-S129 , 2022

Link: https://doi.org/10.1016/..

11

Clinical outcomes in patients with relapsed/refractory FLT3..:

Perl, Alexander E. ; Hosono, Naoko ; Montesinos, Pau...
Blood Cancer Journal. 12 (2022) 5 - p. , 2022

Link: https://doi.org/10.1038/..

12

Secondary‐type mutations do not impact prognosis in acute m..:

Wright, Martha F. ; Pozdnyakova, Olga ; Hasserjian, Robert P....
American Journal of Hematology. 97 (2022) 12 - p. , 2022

Link: https://doi.org/10.1002/..

13

Volasertib as a monotherapy or in combination with azacitid..:

Platzbecker, Uwe ; Chromik, Joerg ; Krönke, Jan...
BMC Cancer. 22 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

14

Isocitrate dehydrogenase inhibitor‐driven differentiation m..:

Rasche, Adrianne ; Mason, Emily F. ; Strickland, Stephen A...
British Journal of Haematology. 194 (2021) 5 - p. 927-931 , 2021

Link: https://doi.org/10.1111/..

15

Results of a randomized phase 3 study of oral sapacitabine ..:

Kantarjian, Hagop M. ; Begna, Kebede H. ; Altman, Jessica K....
Cancer. 127 (2021) 23 - p. 4421-4431 , 2021

Link: https://doi.org/10.1002/..